Role of WT1 in Measurable Residual Disease Follow-Up in the Post Allogeneic Stem Cell Transplant Setting.

导出 LinkOut

翻译打印收藏纠错

作者： Sinem,Namdaroğlu ^[1] ; Semih,Başcı ^[1] ; Burcu,Aslan Candır ^[2] ; Samet,Yaman ^[2] ; Tuğçe Nur,Yiğenoğlu ^[2] ; Taha,Bahsi ^[3] ; Nurgül,Özcan ^[2] ; Mehmet Sinan,Dal ^[2] ; Merih,Kızıl Çakar ^[2] ; Fevzi,Altuntaş ^[2]

作者单位： Department of Hematology and Bone Marrow Transplantation Center, Dokuz Eylul University Hospital, Izmir 35330, Turkey. ^[1] Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara 06200, Turkey. ^[2] Department of Genetics, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara 06200, Turkey. ^[3]

关键词 Wilms’ tumor 1 acute myeloid leukemia allogeneic hematopoietic cell transplantation chimerism flow cytometry polymerase chain reaction

DOI 10.3390/jcm13175145

PMID 39274359

发布时间 2024-09-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of clinical medicine

2024年13卷17期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Role of WT1 in Measurable Residual Disease Follow-Up in the Post Allogeneic Stem Cell Transplant Setting.

Journal of clinical medicine

相似文献

Journal of clinical medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Role of WT1 in Measurable Residual Disease Follow-Up in the Post Allogeneic Stem Cell Transplant Setting.

Journal of clinical medicine

相似文献

Journal of clinical medicine

相关期刊

检索历史清除